A detailed history of Gofen & Glossberg LLC transactions in Dexcom Inc stock. As of the latest transaction made, Gofen & Glossberg LLC holds 6,000 shares of DXCM stock, worth $416,939. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$416,939
Previous $483,000 40.58%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 14, 2022

BUY
$67.99 - $132.89 $305,411 - $596,941
4,492 Added 297.88%
6,000 $447,000
Q4 2021

Jan 25, 2022

BUY
$129.87 - $162.82 $1,038 - $1,302
8 Added 0.53%
1,508 $810,000
Q4 2019

Jan 28, 2020

BUY
$36.62 - $57.29 $54,929 - $85,935
1,500 New
1,500 $328,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.